BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,600 | +0.6% | 20,000 | 0.0% | 0.12% | +14.2% |
| Q2 2023 | $140,800 | +84211.4% | 20,000 | 0.0% | 0.11% | -19.1% |
| Q1 2023 | $167 | -27.4% | 20,000 | 0.0% | 0.13% | -19.1% |
| Q4 2022 | $230 | -99.9% | 20,000 | 0.0% | 0.16% | -8.5% |
| Q3 2022 | $252,000 | +18.9% | 20,000 | 0.0% | 0.18% | +14.9% |
| Q2 2022 | $212,000 | -34.8% | 20,000 | 0.0% | 0.15% | -34.2% |
| Q1 2022 | $325,000 | +17.3% | 20,000 | 0.0% | 0.23% | +30.7% |
| Q4 2021 | $277,000 | -3.5% | 20,000 | 0.0% | 0.18% | -8.2% |
| Q3 2021 | $287,000 | -9.2% | 20,000 | 0.0% | 0.20% | +3.2% |
| Q2 2021 | $316,000 | +55.7% | 20,000 | 0.0% | 0.19% | +56.2% |
| Q1 2021 | $203,000 | +36.2% | 20,000 | 0.0% | 0.12% | +40.7% |
| Q4 2020 | $149,000 | +8.0% | 20,000 | -50.0% | 0.09% | +87.0% |
| Q3 2020 | $138,000 | +45.3% | 40,000 | +100.0% | 0.05% | -19.3% |
| Q2 2020 | $95,000 | +137.5% | 20,000 | 0.0% | 0.06% | +62.9% |
| Q1 2020 | $40,000 | -42.0% | 20,000 | 0.0% | 0.04% | -30.0% |
| Q4 2019 | $69,000 | +21.1% | 20,000 | 0.0% | 0.05% | +31.6% |
| Q3 2019 | $57,000 | -25.0% | 20,000 | 0.0% | 0.04% | -17.4% |
| Q2 2019 | $76,000 | – | 20,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |